Advertisement superDimension secures $22.3 million in equity financing - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

superDimension secures $22.3 million in equity financing

superDimension, a private company that develops minimally invasive interventional pulmonology devices, has completed a round of private equity financing totaling $22.3 million.

The company’s first product, the inReach System, provides minimally invasive electromagnetic navigation (similar to GPS) to distant regions of the lungs, enabling doctors to diagnose lung cancer at earlier stages and potentially provide more timely treatment.

Daniel Sullivan, president and CEO of superDimension, said: “This round of financing will accelerate the company’s investment in sales and marketing to meet and accelerate the growing worldwide demand for inReach.”